Skip navigation

Bristol-Myers posts 33 percent profit jump in 1Q

Drugmaker Bristol-Myers Squibb Co. said Thursday its first-quarter profit jumped 33 percent, due to higher sales, a payment from a lawsuit and a charge a year earlier. Full story

Sanofi-Aventis reports drop in Q1 earnings

Sanofi-Aventis SA saw its earnings fall by nearly 30 percent in the first quarter as low swine flu vaccine sales battered the French drug maker's bottom line. Full story

Earnings Preview: Bristol-Myers reports 1Q results

Drugmaker Bristol-Myers Squibb Co., which recently got approval of an important new skin cancer drug but is facing a sharp revenue drop next year, will report first-quarter results before the stock market opens Thursday. Full story

Aspirin, other meds linked to stomach bleeding risks

NEW YORK (Reuters Health) - People taking low doses of aspirin to protect their heart may be at risk for stomach bleeding, and those taking both aspirin and other common drugs may have an even higher bleeding risk, according to a new study. Full story

New gene variation predicts response to Plavix

German scientists have found a new genetic basis for why some patients respond better to the anti-clotting medicine Plavix, which could be used to test people before they get the world's second-biggest drug. Full story

FDA: Some patients can't process Plavix

   The FDA is putting its strongest warning label on the heart drug Plavix, cautioning that it doesn't work properly in some patients. NBC's Brian Williams reports.

Sponsored Links


FDA says Prilosec can block benefits of Plavix

Study: Plavix plus aspirin helps prevent strokes

Plavix may be less effective in some patients

Plavix plus heartburn drugs may up heart risk

advertisement | ad info